A GTB survey compiled a list of private investment topics for each GTB bio-innovation promotion centre. It found that the total amount for the entire Tokyo region amounts to JPY 500 billion/2 years, mainly in infrastructure development, start-up funding and IPOs.
Private investment in the Tokyo region reaches JPY 500 billion Read More »
The JBA survey found that 12 of the 17 certified biopharmaceutical manufacturing sites have manufacturing and head office functions in the Tokyo area. Others, such as biofoundries.
Certified biopharmaceutical manufacturing sites are concentrated in the Tokyo area Read More »
Introduction of Japan’s bioeconomy strategy and Japan’s leading biocommunity, one of which is Greater Tokyo Biocommunity (GTB). contents: Japan’s Bioeconomy Strategy -Global Trends, Japan’s Bioeconomy Strategy, Bio-Based Market, Japan’s Leading Biocommunity, Data Linkage Greater Tokyo Biocommunity (GTB) -Potential of Tokyo Area, Bio-innovation Promotion Areas, GTB Council, Goal and Approaches, KPI, Typical Progress, Tools for sharing activities For details, please see the documents below. Documents
An Overview of Japan’s Bioeconomy Strategy and Greater Tokyo Biocommunity Read More »
Japan Bioindustry Association (JBA) and NPO Kinki Bio-Industry Development Organization (KBDO) jointly publish and manage “Japanese Life Science Startup List,” a database to introduce the activities of various types of Japanese life science startups. Currently, 225 and 140 startups are included in the Japanese and English pages of the database, respectively. The English page is available at: https://area34.smp.ne.jp/area/table/5697/FDN_H3/M?S=lbsfn2mbnak. If you are interested in biotech startups or looking for novel life science technologies or biotech products, please take a look at our list.
Japanese Life Science Startup List Read More »
As stated in the Master Activity Plan, GTB has set the growth indicators (KPIs) to visualize the results of its activities. The prime KPI is the total sales of member companies of the five biotechnology-related organizations in the GTB area (listed companies and non-listed companies for which sales figures are available; hereinafter referred to as “member companies”), with the goal of expanding total sales from 102 trillion yen in FY2020 to 145 trillion yen by 2030 through annual growth of 3.6% (*The current status and target figures have been slightly revised due to the recalculation.). Here, we are pleased to announce that we have calculated the figures as of FY2021.
Greater Tokyo Biocommunity (GTB) has been certified by Japanese Government as a global biocommunity. The GTB is composed of eight areas: Tsukuba, Kashiwanoha, Hongo/Ochanomizu/Tokyo Station, Nihonbashi, Kawasaki, Yokohama, Shonan, and Chiba/Kazusa. Each area has incubation facilities for startups/ventures to promote the seeds to effective commercialization. This time, a list of these GTB incubation facilities has been created for the startups/ventures looking for the incubation facility in GTB of Japan. GTB Bio-innovation Promotion Areas If interested, please download the list below. ＊Please download the latest version of the list from the GTB website <https://gtb.jba.or.jp/en/gtb-resource-2/>. List (MS Excel) Image of Incubation List
Greater Tokyo Biocommunity (GTB) incubation facility list has been opened. Read More »
The Greater Tokyo Biocommunity (GTB) was established in October 2021 to strengthen the bioindustry ecosystem and achieve the goal of “realizing the world’s most advanced bioeconomy society by 2030,” as stated in the national government’s “Bioeconomy Strategy 2020“. GTB promotes the formation of a global biocommunity hub in Tokyo and its surrounding areas (hereafter referred to as the “greater Tokyo area”), with the participation of a total of 45 organizations including local governments, universities, research institutes, bio-related organizations, industry support organizations, and financial and investment institutions. In April of this year, the GTB received accreditation as a global bio-community from the national government, and is on the verge of accelerating
GTB: Its Advantage on Research, Drug Pipelines and Patents Read More »
The first general meeting of the Greater Tokyo Biocommunity (GTB) Council was held on Tuesday, October 5, 2021, marking the official launch of the GTB. Mr. NAGAYAMA Osamu, President of the Japan Bioindustry Association (JBA), was elected as Chairman of the Council, and Mr. MIYASAKA Manabu, Vice Governor of the Tokyo Metropolitan Government, and Dr. WATANABE Toshiya, Vice President of the University of Tokyo, were elected as Vice Chairmen. The GTB will build a strategic value chain by integrating and networking various organizations that perform various functions from R&D to commercialization, and will also establish a system to become a “bio-innovation hub” that attracts human resources and investment from around
The first general meeting of the GTB Council was held! Read More »
On Tuesday, August 3, 2021, the first preparatory meeting of the Greater Tokyo Biocommunity (GTB) was held. In addition to the participating organizations such as local governments, academia, and industry support organizations, observers from related ministries and agencies participated in the meeting. Of the 140 participants, most were able to attend online, but those who were able took all possible measures to prevent infection and gathered at the real venue, Gakushi Kaikan. The participants were introduced to the overall picture of the Bioeconomy Strategy and activities in collaboration with GTB, and had a free discussion on what to expect from GTB in the future. The first meeting (general meeting) is
The first GTB meeting, the Preparatory Meeting, was held! Read More »
